Platelet-rich plasma (PRP), also known as blood spinning, is among the class of therapies that heighten the human body’s ability to heal itself faster. Although it started making the headlines only recently, platelet rich plasma therapy has been in use since the 1970s, when it was primarily used in dentistry.
Here’s how it works: A medical practitioner extracts an ounce or two of blood from an individual’s vein. The blood is then put into a centrifuge and spun so the platelets separate. The platelets are what secrete growth factors that allow blood to clot and the healing process to begin. The spun blood – which is now rich in plasma – is injected back into the individual’s body at the desired site where it helps expedite injured tissue repair.
With several success stories centered on the use of platelet rich plasma coming to the fore, consumers in Europe are expected to be more open to trying the therapy in a bid to fix orthopedic problems, for aesthetic procedures, and during neurosurgery. The Europe platelet rich plasma market was valued at US$42.1 mn in 2013, says market intelligence firm Transparency Market Research. This market is projected to stand at US$87.2 mn in 2022, registering an 8.3% CAGR between 2014 and 2022.
With Famous Sports Persons Endorsing the Therapy, Europe Platelet Rich Plasma Market Gains Immensely
The most celebrated sportspersons are constantly trying to outdo their best performance. But to do this, they’re also heavily reliant on the use of new treatments that can help them best their previous record – PRP is featuring prominently in the list of therapies that can help them meet this end.
With platelet-rich plasma being aggressively marketed as a cure-all for sports injuries, it’s not surprising that the treatment is becoming popular among sports persons – from Spanish tennis ace Rafael Nadal to American golfer Tiger Woods to American basketball player Kobe Bryant.
Driven by the proven success of platelet rich plasma in treating various orthopedic conditions, it isn’t surprising that in the Europe PRP market, the demand for the therapy in orthopedic applications was the highest. According to TMR, orthopedic procedures accounted for 38.3% of the Europe platelet rich plasma market in 2013.
Use of Platelet Rich Plasma Therapy Accelerating in Cosmetic Procedures
Facials and other skin treatment procedures that use platelet rich plasma therapy as a base are drawing much attention in the skincare and cosmetic industry. Celebrities such as actor Kim Kardashian, who have undergone PRP therapy foe aesthetic reasons, have encouraged many others across the world to approach dermatologists for similar procedures.
A platelet rich plasma facial entails the extraction of blood from a person’s arm. The sample is then spun at high speeds in a machine to separate and concentrate the platelets. The plasma thus extracted is applied on a person’s face using extremely tiny needles – a procedure that doesn’t cause much pain or discomfort. Doctors say that this cosmetic procedure helps the skin build greater amounts of elastin and collagen to rejuvenate itself. The use of platelet rich plasma in cosmetic surgeries will thus help drive the Europe PRP market ahead.
Although there have been some reports that PRP hasn’t suited patients (Nadal, for one, said that he had to stop playing tennis for seven months the second time he took PRP as it didn’t work effectively), most patients typically report relief within a few weeks of undergoing PRP therapy. As more trials are conducted to improve the outcomes of platelet rich plasma therapy, the market will continue to surge ahead, not just in Europe but worldwide.
Browse Research Release: http://www.transparencymarketresearch.com/pressrelease/europe-platelet-rich-plasma-industry.htm